← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Enzerna Biosciences, Llc
Morrisville, NC
$1,385,909
Total funding
6
Grants
Funding over time
peak $259.1K · FY2016–22$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,385,909 · 6
By mechanism
R43$902,674 · 4
R44$259,142 · 1
R41$224,093 · 1
Investigators at Enzerna Biosciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of allele-specific protein-based therapeutic targeting the pathogenic RNA associated with Spinocerebellar ataxia type 3$259,142
R44 · FY2022 · NS
Protein-based Therapeutics to treat nucleotide expansion disorders associated with aberrant gene expression$231,045
R43 · FY2020 · GM
Novel tools for site-specific ablation of the mitochondrial genome$224,968
R43 · FY2016 · GM
Creation of animal models of mitochondrial DNA disease for translational research applications$224,093
R41 · FY2017 · GM
Ablation of the pathogenic RNA transcript associated with myotonic dystrophy, DM1$223,951
R43 · FY2019 · AR
Targeted Degradation of CAG Repeat Expanded Huntingtin mRNA, Associated with Huntington's Disease, Using Artificial Site-Specific RNA Endonucleases$222,710
R43 · FY2018 · NS